Cargando…

Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells

Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that, while Angiotensin-converting enzyme 2 (ACE2) is expressed in these cells, blocking ACE2 by antibody treatment did not p...

Descripción completa

Detalles Bibliográficos
Autores principales: Uppal, Sheetal, Postnikova, Olga, Villasmil, Rafael, Rogozin, Igor B., Bocharov, Alexander V., Eggerman, Thomas L., Poliakov, Eugenia, Redmond, T. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380832/
https://www.ncbi.nlm.nih.gov/pubmed/37511618
http://dx.doi.org/10.3390/ijms241411860
_version_ 1785080292703207424
author Uppal, Sheetal
Postnikova, Olga
Villasmil, Rafael
Rogozin, Igor B.
Bocharov, Alexander V.
Eggerman, Thomas L.
Poliakov, Eugenia
Redmond, T. Michael
author_facet Uppal, Sheetal
Postnikova, Olga
Villasmil, Rafael
Rogozin, Igor B.
Bocharov, Alexander V.
Eggerman, Thomas L.
Poliakov, Eugenia
Redmond, T. Michael
author_sort Uppal, Sheetal
collection PubMed
description Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that, while Angiotensin-converting enzyme 2 (ACE2) is expressed in these cells, blocking ACE2 by antibody treatment did not prevent infection by SARS-CoV-2 spike pseudovirions, nor did antibody blockade of extracellular vimentin and other cholesterol-rich lipid raft proteins. Next, we implicated the role of cholesterol homeostasis in infection by showing that incubating cells with different cyclodextrins and oxysterol 25-hydroxycholesterol (25-HC) inhibits pseudovirion infection of ARPE-19. However, the effect of 25-HC is likely not via cholesterol biosynthesis, as incubation with lovastatin did not appreciably affect infection. Additionally, is it not likely to be an agonistic effect of 25-HC on LXR receptors, as the LXR agonist GW3965 had no significant effect on infection of ARPE-19 cells at up to 5 μM GW3965. We probed the role of endocytic pathways but determined that clathrin-dependent and flotillin-dependent rafts were not involved. Furthermore, 20 µM chlorpromazine, an inhibitor of clathrin-mediated endocytosis (CME), also had little effect. In contrast, anti-dynamin I/II antibodies blocked the entry of SARS-CoV-2 spike pseudovirions, as did dynasore, a noncompetitive inhibitor of dynamin GTPase activity. Additionally, anti-caveolin-1 antibodies significantly blocked spike pseudotyped lentiviral infection of ARPE-19. However, nystatin, a classic inhibitor of caveolae-dependent endocytosis, did not affect infection while indomethacin inhibited only at 10 µM at the 48 h time point. Finally, we found that anti-LDLR antibodies block pseudovirion infection to a similar degree as anti-caveolin-1 and anti-dynamin I/II antibodies, while transfection with LDLR-specific siRNA led to a decrease in spike pseudotyped lentiviral infection, compared to scrambled control siRNAs. Thus, we conclude that SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR.
format Online
Article
Text
id pubmed-10380832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103808322023-07-29 Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells Uppal, Sheetal Postnikova, Olga Villasmil, Rafael Rogozin, Igor B. Bocharov, Alexander V. Eggerman, Thomas L. Poliakov, Eugenia Redmond, T. Michael Int J Mol Sci Article Here, we present evidence that caveolae-mediated endocytosis using LDLR is the pathway for SARS-CoV-2 virus internalization in the ocular cell line ARPE-19. Firstly, we found that, while Angiotensin-converting enzyme 2 (ACE2) is expressed in these cells, blocking ACE2 by antibody treatment did not prevent infection by SARS-CoV-2 spike pseudovirions, nor did antibody blockade of extracellular vimentin and other cholesterol-rich lipid raft proteins. Next, we implicated the role of cholesterol homeostasis in infection by showing that incubating cells with different cyclodextrins and oxysterol 25-hydroxycholesterol (25-HC) inhibits pseudovirion infection of ARPE-19. However, the effect of 25-HC is likely not via cholesterol biosynthesis, as incubation with lovastatin did not appreciably affect infection. Additionally, is it not likely to be an agonistic effect of 25-HC on LXR receptors, as the LXR agonist GW3965 had no significant effect on infection of ARPE-19 cells at up to 5 μM GW3965. We probed the role of endocytic pathways but determined that clathrin-dependent and flotillin-dependent rafts were not involved. Furthermore, 20 µM chlorpromazine, an inhibitor of clathrin-mediated endocytosis (CME), also had little effect. In contrast, anti-dynamin I/II antibodies blocked the entry of SARS-CoV-2 spike pseudovirions, as did dynasore, a noncompetitive inhibitor of dynamin GTPase activity. Additionally, anti-caveolin-1 antibodies significantly blocked spike pseudotyped lentiviral infection of ARPE-19. However, nystatin, a classic inhibitor of caveolae-dependent endocytosis, did not affect infection while indomethacin inhibited only at 10 µM at the 48 h time point. Finally, we found that anti-LDLR antibodies block pseudovirion infection to a similar degree as anti-caveolin-1 and anti-dynamin I/II antibodies, while transfection with LDLR-specific siRNA led to a decrease in spike pseudotyped lentiviral infection, compared to scrambled control siRNAs. Thus, we conclude that SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR. MDPI 2023-07-24 /pmc/articles/PMC10380832/ /pubmed/37511618 http://dx.doi.org/10.3390/ijms241411860 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Uppal, Sheetal
Postnikova, Olga
Villasmil, Rafael
Rogozin, Igor B.
Bocharov, Alexander V.
Eggerman, Thomas L.
Poliakov, Eugenia
Redmond, T. Michael
Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title_full Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title_fullStr Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title_full_unstemmed Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title_short Low-Density Lipoprotein Receptor (LDLR) Is Involved in Internalization of Lentiviral Particles Pseudotyped with SARS-CoV-2 Spike Protein in Ocular Cells
title_sort low-density lipoprotein receptor (ldlr) is involved in internalization of lentiviral particles pseudotyped with sars-cov-2 spike protein in ocular cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380832/
https://www.ncbi.nlm.nih.gov/pubmed/37511618
http://dx.doi.org/10.3390/ijms241411860
work_keys_str_mv AT uppalsheetal lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT postnikovaolga lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT villasmilrafael lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT rogozinigorb lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT bocharovalexanderv lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT eggermanthomasl lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT poliakoveugenia lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells
AT redmondtmichael lowdensitylipoproteinreceptorldlrisinvolvedininternalizationoflentiviralparticlespseudotypedwithsarscov2spikeproteininocularcells